Your browser doesn't support javascript.
loading
Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
Tamminen, Kirsi; Salminen, Marjo; Blazevic, Vesna.
Afiliação
  • Tamminen K; Vaccine Development and Immunology/Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland. Electronic address: kirsi.tamminen@tuni.fi.
  • Salminen M; Vaccine Development and Immunology/Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland. Electronic address: marjo.salminen@tuni.fi.
  • Blazevic V; Vaccine Development and Immunology/Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland. Electronic address: vesna.blazevic@tuni.fi.
Clin Immunol ; 229: 108782, 2021 08.
Article em En | MEDLINE | ID: mdl-34118402

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article